Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-Specific Manner
Author Information
Author(s): Talbot Konrad, Louneva Natalia, Cohen Julia W., Kazi Hala, Blake Derek J., Arnold Steven E.
Primary Institution: University of Pennsylvania
Hypothesis
Are synaptic reductions of dysbindin-1 isoforms in schizophrenia isoform-specific?
Conclusion
The study found that dysbindin-1 isoforms are reduced in schizophrenia in a specific manner, affecting auditory processing and cognitive functions.
Supporting Evidence
- 92% of schizophrenia cases showed reductions in dysbindin-1A averaging 48%.
- 67% of cases showed reductions in dysbindin-1B averaging 33%.
- 80% of cases showed reductions in dysbindin-1C averaging 35%.
- Reductions in dysbindin-1A were significant with p=0.0007.
- Reductions in dysbindin-1B and -1C were significant with p=0.0256 and p=0.0171 respectively.
Takeaway
This study looked at a protein called dysbindin-1 in people with schizophrenia and found that different forms of this protein are reduced in specific brain areas, which might affect how they think and hear things.
Methodology
Western blotting was used to analyze synaptic localization and levels of dysbindin-1 isoforms in brain tissue from schizophrenia cases and matched controls.
Potential Biases
Potential bias due to the matching of cases and controls based on age and sex, but not other factors.
Limitations
The study was limited by the availability of frozen tissue and the need to use different sets of cases for different brain areas.
Participant Demographics
The study included 30 participants, with a mix of males and females, and primarily Caucasian and African-American individuals.
Statistical Information
P-Value
p=0.0007
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website